Lentivirus-mediated RNA Interference Targeting STAT4 Inhibits the Proliferation of Vascular Smooth Muscle Cells

Archives of Medical Research

Volumn 39, Issue 6, 2008, Pages 582-589

  Lv, Lei ^a   Zhang, Jiwei ^a   Huang, Xiaozhong ^a   Zhao, Yiping ^a   Zhou, Zhaoxiong ^a   Zhang, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Activator transcription 4; Restenosis; Signal transducer; Small interfering RNA; Vascular smooth muscle cells

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TETRAZOLIUM;

ANGIOPLASTY; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTIMA; LENTIVIRINAE; METHODOLOGY; NEWBORN PERIOD; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CLONING, MOLECULAR; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LENTIVIRUS; MUSCLE, SMOOTH, VASCULAR; RNA INTERFERENCE; STAT4 TRANSCRIPTION FACTOR; TRANSDUCTION, GENETIC;

EID: 47749095400     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.06.001     Document Type: Article

References (36)

1. Swedberg S.H., Brown B.G., Sigley R., Wight T.N., Gordon D., and Nicholls S.C. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80 (1989) 1726-1736
2. MacDonald J.D., Gyorke A., Jacobs J.M., Mohammad S.F., Sunderland P.M., and Reichman M.V. Acute phase vascular endothelial injury: a comparison of temporary arterial occlusion using an endovascular occlusive balloon catheter versus a temporary aneurysm clip in a pig model. Neurosurgery 34 (1994) 876-881
3. Walker L.N., Bowen-Pope D.F., Ross R., and Reidy M.A. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 83 (1986) 7311-7315
4. Gibbons G.H., Pratt R.E., and Dzau V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta1 expression determines growth response to angiotensin II. J Clin Invest 90 (1992) 456-461
5. Bennett M.R., Anglin S., McEwan J.R., Jagoe R., Newby A.C., and Evan G.I. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 93 (1994) 820-828
6. Hou Y., Okamoto C., Okada K., Kawao N., Kawata S., Ueshima S., et al. c-Myc is essential for urokinase plasminogen activator expression on hypoxia-induced vascular smooth muscle cells. Cardiovasc Res 75 (2007) 186-194
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 (1995) 251-276
8. Wurster A.L., Tanaka T., and Grusby M.J. The biology of Stat4 and Stat6. Oncogene 19 (2000) 2577-2584
9. Yamamoto K., Quelle F.W., Thierfelder W.E., Kreider B.L., Gilbert D.J., Jenkins N.A., et al. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 14 (1994) 4342-4349
10. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 91 (1994) 4806-4810
11. Yamamoto K., Kobayashi H., Arai A., Miura O., Hirosawa S., and Miyasaka N. cDNA cloning, expression and chromosome mapping of the human STAT4 gene: both STAT4 and STAT1 genes are mapped to 2q32.2fi q32.3. Cytogenet Cell Genet 77 (1997) 207-210
12. Guo F., Zarella C., and Wagner W.D. STAT4 and the proliferation of artery smooth muscle cells in atherosclerosis. Exp Mol Pathol 81 (2006) 15-22
13. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33 (2003) 401-406
14. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
15. Miyagishi M., Sumimoto H., Miyoshi H., Kawakami Y., and Taira K. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells. J Gene Med 6 (2004) 715-723
16. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F.H., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
17. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 72 (1998) 8463-8471
18. Pfeifer A., Kessler T., Silletti S., Cheresh D.A., and Verma I.M. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci USA 97 (2000) 12227-12232
19. Naldini L., Blömer U., Gage F.H., Trono D., and Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93 (1996) 11382-11388
20. Torpey N., Maher S.E., Bothwell A.L., and Pober J.S. Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells. J Biol Chem 279 (2004) 26789-26796
21. Matta H., Hozayev B., Tomar R., Chugh P., and Chaudhary P.M. Use of lentiviral vectors for delivery of small interfering RNA. Cancer Biol Ther 2 (2003) 206-210
22. Abbas-Terki T., Blanco-Bose W., Déglon N., Pralong W., and Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther 13 (2002) 2197-2201
23. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Möpps B., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 96 (2005) 784-791
24. Céfaï D., Simeoni E., Ludunge K.M., Driscoll R., von Segesser L.K., Kappenberger L., et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo. J Mol Cell Cardiol 38 (2005) 333-344
25. Dishart K.L., Denby L., George S.J., Nicklin S.A., Yendluri S., Tuerk M.J., et al. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J Mol Cell Cardiol 35 (2003) 739-748
26. Niculescu F., Soane L., Badea T., Shin M., and Rus H. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology 42 (1999) 187-193
27. Dumler I., Kopmann A., Wagner K., Mayboroda O.A., Jerke U., Dietz R., et al. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells. J Biol Chem 274 (1999) 24059-24065
28. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2 (2002) 410-416
29. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374 (2003) 1-20
30. Yamamoto K., Yamaguchi M., Miyasaka N., and Miura O. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. Biochem Biophys Res Commun 310 (2003) 1188-1193
31. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
32. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Mol Cell 2 (1998) 275-281
33. Egashira K., Zhao Q., Kataoka C., Ohtani K., Usui M., Charo I.F., et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90 (2002) 1167-1172
34. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 (1991) 1121-1127
35. Coll B., Alonso-Villaverde C., and Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?. Clin Chim Acta 383 (2007) 21-29
36. Parenti A., Bellik L., Brogelli L., Filippi S., and Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286 (2004) 1978-1984